296 related articles for article (PubMed ID: 36774930)
1. Hepatitis B.
Jeng WJ; Papatheodoridis GV; Lok ASF
Lancet; 2023 Mar; 401(10381):1039-1052. PubMed ID: 36774930
[TBL] [Abstract][Full Text] [Related]
2. Effect on HBs antigen clearance of addition of pegylated interferon alfa-2a to nucleos(t)ide analogue therapy versus nucleos(t)ide analogue therapy alone in patients with HBe antigen-negative chronic hepatitis B and sustained undetectable plasma hepatitis B virus DNA: a randomised, controlled, open-label trial.
Bourlière M; Rabiega P; Ganne-Carrie N; Serfaty L; Marcellin P; Barthe Y; Thabut D; Guyader D; Hezode C; Picon M; Causse X; Leroy V; Bronowicki JP; Carrieri P; Riachi G; Rosa I; Attali P; Molina JM; Bacq Y; Tran A; Grangé JD; Zoulim F; Fontaine H; Alric L; Bertucci I; Bouvier-Alias M; Carrat F;
Lancet Gastroenterol Hepatol; 2017 Mar; 2(3):177-188. PubMed ID: 28404133
[TBL] [Abstract][Full Text] [Related]
3. Study on the Retreatment, Outcome, and Potential Predictors of Recurrence in Patients With Recurrence of Hepatitis B After Functional Cure.
Lin X; Song A; Lu J; Zheng S; Hu Z; Ma L; Cao Z; Li H; Zheng Y; Ren S; Chen X
Front Immunol; 2022; 13():879835. PubMed ID: 35860247
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus: from diagnosis to treatment.
Dény P; Zoulim F
Pathol Biol (Paris); 2010 Aug; 58(4):245-53. PubMed ID: 20580167
[TBL] [Abstract][Full Text] [Related]
5. How to achieve functional cure of HBV: Stopping NUCs, adding interferon or new drug development?
Wong GLH; Gane E; Lok ASF
J Hepatol; 2022 Jun; 76(6):1249-1262. PubMed ID: 35589248
[TBL] [Abstract][Full Text] [Related]
6. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
7. What will it take to cure hepatitis B?
Jeng WJ; Lok ASF
Hepatol Commun; 2023 Apr; 7(4):. PubMed ID: 36972391
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of viral hepatitis B markers among blood donors in the Republic of Guinea].
Boumbaly S; Balde TAL; Semenov AV; Ostankova YV; Serikova EN; Naidenova EV; Valutite DE; Shchemelev AN; Zueva EB; Esaulenko EV; Totolian AA
Vopr Virusol; 2022 Mar; 67(1):59-68. PubMed ID: 35293189
[TBL] [Abstract][Full Text] [Related]
9. How to interpret viral markers in the management of chronic hepatitis B infection.
Riveiro-Barciela M; Pericàs JM; Buti M
Clin Microbiol Infect; 2022 Mar; 28(3):355-361. PubMed ID: 34768018
[TBL] [Abstract][Full Text] [Related]
10. Latest developments in the treatment of hepatitis B.
Dandri M; Petersen J
Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309
[TBL] [Abstract][Full Text] [Related]
11. Toward a complete cure for chronic hepatitis B: Novel therapeutic targets for hepatitis B virus.
Kim SW; Yoon JS; Lee M; Cho Y
Clin Mol Hepatol; 2022 Jan; 28(1):17-30. PubMed ID: 34281294
[TBL] [Abstract][Full Text] [Related]
12. Prevention of hepatocellular carcinoma in hepatitis B virus infection.
Lim SG; Mohammed R; Yuen MF; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1352-7. PubMed ID: 19702903
[TBL] [Abstract][Full Text] [Related]
13. HBsAg Loss as a Treatment Endpoint for Chronic HBV Infection: HBV Cure.
Moini M; Fung S
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458387
[TBL] [Abstract][Full Text] [Related]
14. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection.
;
J Hepatol; 2017 Aug; 67(2):370-398. PubMed ID: 28427875
[TBL] [Abstract][Full Text] [Related]
15. Nationwide retrospective study of hepatitis B virological response and liver stiffness improvement in 465 patients on nucleos(t)ide analogue.
Ramji A; Doucette K; Cooper C; Minuk GY; Ma M; Wong A; Wong D; Tam E; Conway B; Truong D; Wong P; Barrett L; Ko HH; Haylock-Jacobs S; Patel N; Kaplan GG; Fung S; Coffin CS
World J Gastroenterol; 2022 Aug; 28(31):4390-4398. PubMed ID: 36159017
[TBL] [Abstract][Full Text] [Related]
16. Update on hepatitis B virus infection.
You CR; Lee SW; Jang JW; Yoon SK
World J Gastroenterol; 2014 Oct; 20(37):13293-305. PubMed ID: 25309066
[TBL] [Abstract][Full Text] [Related]
17. Towards a Functional Cure for Hepatitis B Virus: A 2022 Update on New Antiviral Strategies.
Degasperi E; Anolli MP; Lampertico P
Viruses; 2022 Oct; 14(11):. PubMed ID: 36366502
[TBL] [Abstract][Full Text] [Related]
18. Chronic Hepatitis B Infection: A Review.
Tang LSY; Covert E; Wilson E; Kottilil S
JAMA; 2018 May; 319(17):1802-1813. PubMed ID: 29715359
[TBL] [Abstract][Full Text] [Related]
19. New assays for quantitative determination of viral markers in management of chronic hepatitis B virus infection.
Zoulim F; Mimms L; Floreani M; Pichoud C; Chemin I; Kay A; Vitvitski L; Trepo C
J Clin Microbiol; 1992 May; 30(5):1111-9. PubMed ID: 1583107
[TBL] [Abstract][Full Text] [Related]
20. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration.
Hunt CM; Beste LA; Lowy E; Suzuki A; Moylan CA; Tillmann HL; Ioannou GN; Lim JK; Kelley MJ; Provenzale D
World J Gastroenterol; 2016 May; 22(19):4732-40. PubMed ID: 27217704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
